ANOBRI
Live / Registered — Registered (as of 24 Mar 2026)
What this means for you
Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98002612
- Registration number
- 8188203
- Mark type
- Stylized text
- Filed
- 18 May 2023
- Published for opposition
- 02 Apr 2024
- Registered
- 24 Mar 2026
- Attorney of record
- Sloan Carpenter
Goods and services
- Class 005 — Pharmaceuticals: Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with pharmaceutical preparations for treating respiratory diseases and disorders; Medicated throat sprays; Pharmaceutical products for treating respiratory diseases and asthma
Owner
- ANOBRI PHARMACEUTICALS US, LLC, NEWARK, NJ, US
- ANOBRI PHARMACEUTICALS US, LLC, NEWARK, NJ, US
- ANOBRI PHARMACEUTICALS US, LLC, NEWARK, NJ, US
- ANOVENT PHARMACEUTICAL (U.S.), LLC, Newark, NJ, US
Prosecution history
- 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Mar 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 16 Jan 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 16 Jan 2026 — FINAL REFUSAL E-MAILED
- 16 Jan 2026 — SU - FINAL REFUSAL - WRITTEN
- 15 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Jan 2026 — ASSIGNED TO LIE
- 09 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED